Phase II Study of Combination Chemotherapy with Etoposide and Ifosfamide in Patients with Heavily Pretreated Recurrent or Persistent Epithelial Ovarian Cancer

The aim of this trial was to investigate the efficacy and toxicity of combination chemotherapy with etoposide and ifosfamide (ETI) in the management of heavily pretreated recurrent or persistent epithelial ovarian cancer (EOC). Patients with recurrent or persistent EOC who had measurable disease and...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kang, Heeseok, Kim, Tae-Joong, Choi, Chel Hun, Lee, Jeong-Won, Lee, Je-Ho, Bae, Duk-Soo, Kim, Byoung-Gie
Formato: Artigo
Lenguaje:Inglês
Publicado: The Korean Academy of Medical Sciences 2009
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2752782/
https://ncbi.nlm.nih.gov/pubmed/19794997
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2009.24.5.945
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares